Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.

Hollander P, Kamper P, Smedby KE, Enblad G, Ludvigsen M, Mortensen J, Amini RM, Hamilton-Dutoit S, d'Amore F, Molin D, Glimelius I.

Blood Adv. 2017 Aug 8;1(18):1427-1439. doi: 10.1182/bloodadvances.2017006346. eCollection 2017 Aug 8.

2.

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.

Hollander P, Rostgaard K, Smedby KE, Molin D, Loskog A, de Nully Brown P, Enblad G, Amini RM, Hjalgrim H, Glimelius I.

Eur J Haematol. 2018 Jan;100(1):88-97. doi: 10.1111/ejh.12987. Epub 2017 Nov 14.

PMID:
29064587
3.

KIT signaling is dispensable for human mast cell progenitor development.

Dahlin JS, Ekoff M, Grootens J, Löf L, Amini RM, Hagberg H, Ungerstedt JS, Olsson-Strömberg U, Nilsson G.

Blood. 2017 Oct 19;130(16):1785-1794. doi: 10.1182/blood-2017-03-773374. Epub 2017 Aug 8.

5.

Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing.

Enblad G, Martinsson G, Baecklund E, Hesselager G, Sundström C, Amini RM, Hagberg H.

Acta Oncol. 2017 Apr;56(4):599-607. doi: 10.1080/0284186X.2016.1270465. Epub 2017 Jan 13.

PMID:
28084866
6.

Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing.

Quentmeier H, Drexler HG, Hauer V, MacLeod RA, Pommerenke C, Uphoff CC, Zaborski M, Berglund M, Enblad G, Amini RM.

PLoS One. 2016 Dec 1;11(12):e0167599. doi: 10.1371/journal.pone.0167599. eCollection 2016.

7.

Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research.

Abdulla M, Laszlo S, Triumf J, Hedström G, Berglund M, Enblad G, Amini RM.

Acta Oncol. 2017 Jan;56(1):106-109. doi: 10.1080/0284186X.2016.1245863. Epub 2016 Oct 31. No abstract available.

PMID:
27796168
8.

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.

Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V, Schneider M, Yoshida K, Skaftason A, Pandzic T, Gonzalez B, Tasidou A, Waldhueter N, Rivas-Delgado A, Angelopoulou M, Ziepert M, Arends CM, Couronné L, Lenze D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J, Dörken B, Drexler HG, Roos-Weil D, Schmitt CA, Munch-Petersen HD, Zenz T, Hansmann ML, Strefford JC, Enblad G, Bernard OA, Ralfkiaer E, Erlanson M, Korkolopoulou P, Hultdin M, Papadaki T, Grønbæk K, Lopez-Guillermo A, Ogawa S, Küppers R, Stamatopoulos K, Stavroyianni N, Kanellis G, Rosenwald A, Campo E, Amini RM, Ott G, Vassilakopoulos TP, Hummel M, Rosenquist R, Damm F.

Blood. 2016 Dec 8;128(23):2666-2670. Epub 2016 Sep 26.

9.

A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients.

Abdulla M, Laszlo S, Triumf J, Hedström G, Berglund M, Enblad G, Amini RM.

Acta Oncol. 2016 Sep - Oct;55(9-10):1126-1131. doi: 10.1080/0284186X.2016.1189093. Epub 2016 Aug 23.

PMID:
27549735
10.

Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker.

Hasni MS, Berglund M, Yakimchuk K, Guan J, Linderoth J, Amini RM, Enblad G, Okret S.

Leuk Lymphoma. 2017 Feb;58(2):418-427. Epub 2016 Jun 29.

PMID:
27357538
11.

Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma.

Pommerenke C, Hauer V, Zaborski M, MacLeod RA, Nagel S, Amini RM, Berglund M, Geffers R, Drexler HG, Quentmeier H.

Blood Cancer J. 2016 Jun 10;6:e433. doi: 10.1038/bcj.2016.43. No abstract available.

12.

Optimal model of PDIG based microgrid and design of complementary stabilizer using ICA.

Amini RM, Safari A, Ravadanegh SN.

ISA Trans. 2016 Sep;64:328-341. doi: 10.1016/j.isatra.2016.04.010. Epub 2016 May 3.

PMID:
27157850
13.

The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children.

Englund A, Molin D, Enblad G, Karlén J, Glimelius I, Ljungman G, Amini RM.

Eur J Haematol. 2016 Nov;97(5):430-438. doi: 10.1111/ejh.12747. Epub 2016 Mar 23.

PMID:
26872637
14.

Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma.

Hollander P, Rostgaard K, Smedby KE, Chang ET, Amini RM, de Nully Brown P, Glimelius B, Adami HO, Melbye M, Glimelius I, Hjalgrim H.

Am J Epidemiol. 2015 Oct 1;182(7):624-32. doi: 10.1093/aje/kwv081. Epub 2015 Sep 6.

15.

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.

Borgquist S, Zhou W, Jirström K, Amini RM, Sollie T, Sørlie T, Blomqvist C, Butt S, Wärnberg F.

BMC Cancer. 2015 Jun 11;15:468. doi: 10.1186/s12885-015-1479-3.

16.

Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study.

Bergfelt E, Kozlowski P, Ahlberg L, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A, Tomaszewska-Toporska B, Smedmyr B, Åström M, Amini RM, Hallböök H.

Med Oncol. 2015 Apr;32(4):135. doi: 10.1007/s12032-015-0582-2. Epub 2015 Mar 22.

PMID:
25796502
17.

Breast cancer with neoductgenesis: histopathological criteria and its correlation with mammographic and tumour features.

Zhou W, Sollie T, Tot T, Pinder SE, Amini RM, Blomqvist C, Fjällskog ML, Christensson G, Abdsaleh S, Wärnberg F.

Int J Breast Cancer. 2014;2014:581706. doi: 10.1155/2014/581706. Epub 2014 Oct 8.

18.

Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.

Lundgren C, Ahlin C, Holmberg L, Amini RM, Fjällskog ML, Blomqvist C.

Acta Oncol. 2015 Apr;54(4):538-44. doi: 10.3109/0284186X.2014.965274. Epub 2014 Oct 18.

PMID:
25327158
19.

Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade.

Libard S, Popova SN, Amini RM, Kärjä V, Pietiläinen T, Hämäläinen KM, Sundström C, Hesselager G, Bergqvist M, Ekman S, Zetterling M, Smits A, Nilsson P, Pfeifer S, de Ståhl TD, Enblad G, Ponten F, Alafuzoff I.

PLoS One. 2014 Sep 30;9(9):e108861. doi: 10.1371/journal.pone.0108861. eCollection 2014.

20.

The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma.

Hedström G, Thunberg U, Amini RM, Zainuddin N, Enblad G, Berglund M.

Eur J Haematol. 2014 Dec;93(6):500-8. doi: 10.1111/ejh.12388. Epub 2014 Jun 21.

PMID:
24889555

Supplemental Content

Loading ...
Support Center